MyMD Pharmaceuticals, Inc. (MYMD) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 16 transactions totaling $403.6K, demonstrating a bullish sentiment with $403.6K in net insider flow. The most recent transaction on Aug 24, 2023 involved a purchase of 150,000 shares valued at $166.5K.
No significant insider buying has been recorded for MYMD in the recent period.
No significant insider selling has been recorded for MYMD in the recent period.
Based on recent SEC filings, insider sentiment for MYMD is bullish with an Insider Alignment Score of 100/100 and a net flow of $403.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MyMD Pharmaceuticals, Inc. (MYMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading MYMD stock, having executed 16 transactions in the past 90 days. The most active insider is Paul Rivard (Executive), who has made 4 transactions totaling $300.3K.
Get notified when executives and directors at MYMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | Rivard Paul | Executive | Purchase | 150,000 | $1.11 | $166.5K | |
| Aug 17, 2023 | Rivard Paul | Executive | Purchase | 25,000 | $1.12 | $28.0K | |
| Dec 8, 2022 | Rivard Paul | Executive | Purchase | 10,000 | $1.53 | $15.3K | |
| Nov 26, 2021 | Silverman Joshua | Executive | Purchase | 5,000 | $7.55 | $37.8K | |
| Nov 24, 2021 | Silverman Joshua | Executive | Purchase | 6,734 | $6.30 | $42.4K | |
| Nov 24, 2021 | Silverman Joshua | Executive | Purchase | 3,266 | $7.09 | $23.2K | |
| Nov 23, 2021 | Rivard Paul | Executive | Purchase | 15,000 | $6.03 | $90.5K | |
| Apr 16, 2021 | Joe White Billy | Executive | Payment | 38,325 | $4.94 | $189.3K | |
| Apr 16, 2021 | Joe White Billy | Executive | Option Exercise | 109,500 | $N/A | $0 | |
| Apr 16, 2021 | Silverman Joshua | Executive | Option Exercise | 109,500 | $N/A | $0 | |
| Apr 16, 2021 | Silverman Joshua | Executive | Payment | 38,325 | $4.94 | $189.3K | |
| Apr 16, 2021 | C. Schroeder Robert | Executive | Payment | 14,694 | $4.94 | $72.6K | |
| Apr 16, 2021 | C. Schroeder Robert | Executive | Option Exercise | 43,930 | $N/A | $0 | |
| Apr 16, 2021 | C. Chapman Christopher Jr | Executive | Award | 96,475 | $N/A | $0 | |
| Apr 16, 2021 | C. Schreiber Christopher | Executive | Payment | 46,113 | $4.94 | $227.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 4 | $679.0K | 62.7% |
Purchase(P) | 7 | $403.6K | 37.3% |
Exercise(M) | 4 | $0 | 0.0% |
Award(A) | 1 | $0 | 0.0% |
Insiders at MyMD Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 6 insiders making 16 transactions totaling $403.6K in purchases versus $0 in sales, the net buying activity of $403.6K signals strong executive confidence. Paul Rivard (Executive) leads the buying activity with $300.3K in transactions across all time.